Glaxosmithkline Pharmaceuticals Ltd Net Profit is INR 14.33 crores in Q4 FY 2020-2021

Glaxosmithkline Pharmaceuticals Ltd Q3 FY20-21 Quarter Result { “@context”: “https://schema.org”, “@type”: “NewsArticle”, “Stock”: Glaxosmithkline Pharmaceuticals Ltd, “Quarter Result”: “December 2020”, “Sales”: 813.75 cr, “Net Profit”: 14.33 cr }

Glaxosmithkline Pharmaceuticals Ltd Net Profit is INR 14.33 crores in Quarter 4, January – March of Financial Year 2020-2021.

Quarterly Net Earnings Year-on-Year

Glaxosmithkline Pharmaceuticals Ltd Quarter Net Profit is Down by -90 % from Last Year Quarter and Net Profit of INR 14.33 crores is reported in Quarter 4, January – March of Financial Year 2020-2021. Last Year Quarter 4, January – March of Financial Year 2019-2020 Net Profit was INR 138.07 crores.

Quarterly Net Sales Year-on-Year

Glaxosmithkline Pharmaceuticals Ltd Quarter Sale is up 5 % from Last Quarter. Sales of 813.75 is reported in Quarter 4, January – March of Financial Year 2020-2021. In Last Year Quarter 4, January – March of Financial Year 2019-2020 Sale was 775.8

Annual Sales & Net Earning

Glaxosmithkline Pharmaceuticals Ltd Annual Sales in Financial Year 2019 to 2020 was reported INR 3224.38 crores and Annual Profit in Financial Year 2019 to 2020 was reported INR 93.2 crores.


Glaxosmithkline Pharmaceuticals Ltd Stock Information

SectorPharmaceuticals
IndustryPharmaceuticals – Multinational
AboutGSK India is committed to providing medicines that will improve peoples quality of life and truly make a difference to patients. Their ultimate goal is to leverage the power of science through new innovations in both preventive and curative healthcare and They are a leader in many therapeutic areas where they provide healthcare solutions.(
Latest Qaurter EPS0.845506019314724

Glaxosmithkline Pharmaceuticals Ltd Stock Analysis:

Get more Quarterly Earnings Results of companies

Get complete data on Glaxosmithkline Pharmaceuticals Ltd

Leave a Comment

Your email address will not be published. Required fields are marked *